Active Ingredient: OXCARBAZEPINE
Proprietary Name: TRILEPTAL
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 300MG/5ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021285
Product Number: 001
Approval Date: May 25, 2001
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
